A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Azelaic acid (Primary)
- Indications Rosacea
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bayer
- 31 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 18 Aug 2017 Status changed from not yet recruiting to recruiting.
- 19 Jul 2017 Planned primary completion date changed from 30 Sep 2017 to 31 Oct 2017.